Compugen Ltd
NASDAQ:CGEN

Watchlist Manager
Compugen Ltd Logo
Compugen Ltd
NASDAQ:CGEN
Watchlist
Price: 1.45 USD -1.36% Market Closed
Market Cap: 135.6m USD

Relative Value

The Relative Value of one CGEN stock under the Base Case scenario is 1.44 USD. Compared to the current market price of 1.45 USD, Compugen Ltd is Overvalued by 1%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CGEN Relative Value
Base Case
1.44 USD
Overvaluation 1%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
68
vs Industry
36
Median 3Y
6.5
Median 5Y
8.1
Industry
3.6
Forward
4.2
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-10.6
Industry
29
Forward
-12.2
vs History
15
vs Industry
50
Median 3Y
-2.2
Median 5Y
-5.4
Industry
18.7
vs History
15
vs Industry
34
Median 3Y
-2.1
Median 5Y
-5.4
Industry
31.2
vs History
65
vs Industry
40
Median 3Y
2.1
Median 5Y
2.9
Industry
2.4
vs History
61
vs Industry
73
Median 3Y
1.7
Median 5Y
2.3
Industry
3.4
Forward
0.8
vs History
34
vs Industry
80
Median 3Y
-2
Median 5Y
0
Industry
8
vs History
vs Industry
54
Median 3Y
-1.2
Median 5Y
-7.1
Industry
16
vs History
vs Industry
50
Median 3Y
-1.2
Median 5Y
-6.8
Industry
21.6
Forward
-1.7
vs History
20
vs Industry
53
Median 3Y
-0.1
Median 5Y
-2.3
Industry
17.9
vs History
20
vs Industry
40
Median 3Y
-0.1
Median 5Y
-2.3
Industry
22.9
vs History
52
vs Industry
23
Median 3Y
13.8
Median 5Y
40.3
Industry
2.2

Multiples Across Competitors

CGEN Competitors Multiples
Compugen Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Compugen Ltd
NASDAQ:CGEN
129.8m USD 4.7 -9.2 -1.8 -1.8
US
PerkinElmer Inc
LSE:0KHE
993.5B USD 358.7 3 466.5 1 215.6 2 479.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
148.6B USD 3.5 22.8 16.1 22.2
US
Danaher Corp
NYSE:DHR
132.1B USD 5.5 35.1 19.4 28.3
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW 14.5 55.6 32.3 44.9
CH
Lonza Group AG
SIX:LONN
39.1B CHF 6 61.5 22.6 35.2
US
Agilent Technologies Inc
NYSE:A
31B USD 4.7 24.6 18 21.1
CN
WuXi AppTec Co Ltd
SSE:603259
179.2B CNY 4.4 16.1 15.3 15.3
US
IQVIA Holdings Inc
NYSE:IQV
23.9B USD 1.5 17.9 10.4 15.4
US
Mettler-Toledo International Inc
NYSE:MTD
23.2B USD 6 27.3 20.4 22.6
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.4B EUR 6.4 90.2 28.9 51.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IL
Compugen Ltd
NASDAQ:CGEN
Average EV/EBITDA: 139.9
Negative Multiple: -1.8
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 215.6
7%
173.7
US
Thermo Fisher Scientific Inc
NYSE:TMO
16.1
6%
2.7
US
Danaher Corp
NYSE:DHR
19.4
7%
2.8
KR
Samsung Biologics Co Ltd
KRX:207940
32.3
17%
1.9
CH
Lonza Group AG
SIX:LONN
22.6
18%
1.3
US
Agilent Technologies Inc
NYSE:A
18
10%
1.8
CN
WuXi AppTec Co Ltd
SSE:603259
15.3
24%
0.6
US
IQVIA Holdings Inc
NYSE:IQV
10.4
9%
1.2
US
Mettler-Toledo International Inc
NYSE:MTD
20.4
4%
5.1
FR
Sartorius Stedim Biotech SA
PAR:DIM
28.9
20%
1.4